文献速递皮肤肿瘤

单酰甘油脂肪酶表达作为恶性黑色素瘤侵袭与进展标志物的研究

Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanoma.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2017-08-06

该研究通过PCR阵列筛选和免疫细胞化学验证,发现MAGL在12种黑色素瘤细胞系中均表达,而在正常人表皮黑素细胞中不表达。对74例黑色素瘤样本(48例原发、26例转移)进行免疫组化染色,结果显示MAGL阳性率在原发灶为64.5%,淋巴结转移灶为82.4%,皮肤转移灶为77.8%。转移瘤的染色强度显著更高(淋巴结P=0.033,皮肤P=0.010),且原发灶中MAGL高表达与更大肿瘤厚度(P=0.015)和血管侵犯(P=0.017)相关。结论认为MAGL表达反映黑色素瘤细胞的侵袭性,可能作为肿瘤进展的标志物。

要点

  • MAGL在黑色素瘤细胞系中普遍表达,而在正常黑素细胞中不表达。
  • 转移性黑色素瘤的MAGL染色强度显著高于原发灶。
  • 原发灶MAGL高表达与肿瘤厚度增加和血管侵犯相关。

核心结论

  • MAGL在肿瘤细胞中的表达反映黑色素瘤细胞的侵袭性,可能作为肿瘤进展的标志物。

研究设计与样本

  • 研究采用PCR阵列筛选,并用免疫细胞化学分析肿瘤与非肿瘤黑素细胞系进行验证。
  • 对74例黑色素瘤样本(48例原发、26例转移)进行免疫组化染色,评估MAGL阳性细胞百分比和染色强度。
  • 分析MAGL表达状态与肿瘤进展、原发灶肿瘤厚度及血管侵犯的关联。

主要发现

  • 免疫细胞化学显示MAGL在全部12种黑色素瘤细胞系中表达,但在正常人表皮黑素细胞中不表达。
  • 免疫组化显示MAGL阳性染色在原发灶为32/48(64.5%),淋巴结转移灶为14/17(82.4%),皮肤转移灶为7/9(77.8%)。
  • 转移瘤染色强度显著更高(淋巴结P=0.033,皮肤P=0.010)。
  • 原发灶中MAGL高表达与更大肿瘤厚度(P=0.015)和血管侵犯(P=0.017)相关。
  • 在MAGL阳性原发灶中,肿瘤团块更深区域的染色强度倾向于更高。

临床怎么用

  • MAGL免疫组化染色可能辅助评估黑色素瘤的侵袭性和进展风险。
  • 原发灶MAGL高表达提示需关注肿瘤厚度和血管侵犯情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accumulating evidence suggests that the lipid lytic enzyme monoacylglycerol lipase (MAGL) promotes tumour invasion and metastasis through up-regulation of pro-tumorigenic signalling lipids in several tumour cell lines. However, the expression status of MAGL in clinical melanoma tissues and its clinicopathological significance remain unclear. OBJECTIVE: To correlate the tumour expression status of MAGL with the clinicopathological information of patients with malignant melanoma. METHODS: Polymerase chain reaction (PCR) array screening was performed, and the results were validated using immunocytochemical analysis of tumour and non-tumour melanocytic cell lines. Immunohistochemical staining for MAGL was performed for 74 melanoma samples, including 48 primary and 26 metastatic tumours, in which the expression of MAGL was determined by evaluating the percentage of MAGL-positive tumour cells and the MAGL staining intensity. Finally, we analysed the association of MAGL expression status with tumour progression, tumour thickness and vascular invasion of the primary lesion. RESULTS: Immunocytochemical analysis revealed that MAGL was expressed in all 12 melanoma cell lines, but not in normal human epidermal melanocytes. In the immunohistochemical analysis, positive staining for MAGL was noted in 32 of 48 (64.5%) primary lesions, 14 of 17 (82.4%) lymph node metastatic lesions and 7 of 9 (77.8%) skin metastatic lesions. Metastatic tumours had a significantly higher staining intensity (P = 0.033 for lymph node, P = 0.010 for skin). In the analysis of primary lesions, higher MAGL expression correlated with greater tumour thickness (P = 0.015) and the presence of vascular invasion (P = 0.017). On further evaluation of MAGL-positive primary lesions, staining intensity of MAGL tended to be higher in deeper areas of the tumour mass. CONCLUSIONS: The expression of MAGL in tumour cells reflects the aggressiveness of melanoma cells and may serve as a marker of tumour progression.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Baba Y, Funakoshi T, Mori M, et al. Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanoma. J Eur Acad Dermatol Venereol. 2017. PMID: 28681540. doi:10.1111/jdv.14455

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。